Details of the Drug Reposition

General Information of This Drug (ID: DM78KH5)

Drug Name
AGS-67E   DM78KH5

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [1]
Acute myeloid leukaemia DIS0BM1I 2A60 Phase 1 [2]
Malignant lymphatic vessel tumor DIS01Y4H 2A82 Phase 1 [3]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02175433) A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)